MEDIFAST INC
MEDNYSETrading Snapshot
- Day Range
- $206.88 β $208.91
- 52-Week Range
- $9.22 β $14.15
- Volume
- $3.63B
- Avg Volume
- $4.54B
- Shares Outstanding
- 11.1M
- Next Earnings
- Nov 25, 2026
Fundamentals Snapshot
- Annual Revenue
- $386M
- Last Q Revenue
- $76M
- P/E Ratio
- -5.0
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-2.30
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.1%
Why Investors Own MED
- βHigh-growth profile β revenue up +40.7% YoY with expanding US Equity exposure.
- βHealthy economics β 71% gross margin and 25% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
MEDIFAST INC
MEDAbout MEDIFAST INC
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
MEDIFAST INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift MED price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
MEDIFAST INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.